T-regulatory cell modulation: the future of cancer immunotherapy?

AUTOR(ES)

Nizar, S

FONTE

Nature Publishing Group

RESUMO

T-regulatory cells suppress anti-tumour immunity in cancer patients and in murine tumour models. Furthermore, their activity is likely to have an effect on the effectiveness of immunotherapeutic treatments for cancer. Here we describe the current status of developing clinical strategies for modulating Treg activity in cancer patients.

Documentos Relacionados

• Naturally Occurring and Inducible T-Regulatory Cells Modulating Immune Response in Allergic Asthma
• Modulation of T-Cell Costimulation as Immunotherapy or Immunochemotherapy in Experimental Visceral Leishmaniasis
• Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer
• Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia
• Inhibition of Prostate Cancer Cell Colony Formation by the Flavonoid Quercetin Correlates with Modulation of Specific Regulatory Genes